Spots Global Cancer Trial Database for ag013
Every month we try and update this database with for ag013 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study to Assess Safety and Tolerability of AG013 in Oral Mucositis in Subjects Receiving Induction Chemotherapy for the Treatment of Cancers of the Head and Neck | NCT00938080 | Oral Mucositis | AG013 AG013 AG013 Placebo Placebo Placebo | 18 Years - | ActoGeniX N.V. | |
Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day | NCT03234465 | Oral Mucositis | AG013 Placebo | 21 Years - | Oragenics, Inc. | |
Study to Assess Safety and Tolerability of AG013 in Oral Mucositis in Subjects Receiving Induction Chemotherapy for the Treatment of Cancers of the Head and Neck | NCT00938080 | Oral Mucositis | AG013 AG013 AG013 Placebo Placebo Placebo | 18 Years - | ActoGeniX N.V. |